Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease

ClinicalTrials.gov ID: NCT04987489

Public ClinicalTrials.gov record NCT04987489. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 6:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Open-Label Study to Evaluate Safety and Clinical Activity of Etavopivat in Patients With Thalassemia or Sickle Cell Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This clinical trial is a Phase 2 study that will evaluate the safety and clinical activity of etavopivat in patients with thalassemia or sickle cell disease and test how well etavopivat works to lower the number of red blood cell transfusions required and increase hemoglobin.

Study identification

NCT ID
NCT04987489
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Forma Therapeutics, Inc.
Industry
Enrollment
53 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 28, 2022 (Actual)
Primary completion
Sep 3, 2025 (Actual)
Completion
Sep 24, 2025 (Actual)
Last update posted
Dec 16, 2025

2022 – 2025

United States locations

U.S. sites
14
U.S. states
8
U.S. cities
12
Facility City State ZIP Site status
TOI Clinical Research Cerritos California 90703 —
[Legal] Children's Hospital Los Angeles Los Angeles California 90027 —
University of Californ LA-UCLA Los Angeles California 90095 —
UCSF Oakland Benioff ChildHosp Oakland California 94609 —
[Legal] Children's Hospital of Orange County on behalf of CHOC Children's Hospital of Orange County Orange California 92868 —
UCI Health Orange California 92868 —
Children's National Health Hospital Washington D.C. District of Columbia 20010 —
Children's Hospital of Atlanta Atlanta Georgia 30342 —
[Legal] Dr. Vince Clinical Research, LLC and Dr. Vince Clinical Research, P.A. Detroit Michigan 48201-2018 —
Weill Medical College of Cornell University New York New York 10065 —
Duke University Durham North Carolina 27710 —
East Carolina University Greenville North Carolina 27858 —
[Legal] Children's Hospital Medical Center dba Cincinnati Children's Cincinnati Ohio 45229 —
Children's Hosptl Philadelphia Philadelphia Pennsylvania 19104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04987489, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 16, 2025 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04987489 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →